- Bassett Healthcare Network appoints division chief of dental services
- Why this CIO treated an EHR decision as an operating model reset
- For-profit operators: 43 executive moves in 2026
- HCA Florida hospital names CFO
- Aetna fined $550K for mental health parity violations
- 10 states with lowest, highest dental costs
- Sutter launches neonatal transport program with $10M gift
- BayCare hospital taps new operations leader
- Surgery Partners revenue hits $3.3B in 2025
- Altru completes CommonSpirit hospital acquisition
- Henry Ford hospital nurses strike hits 6-month mark: 4 notes
- Cigna COO to succeed retiring predecessor as CEO
- Staffing mandates won’t cause SNF closures: Study
- Why CommonSpirit is exiting Conifer
- Why CommonSpirit is exiting Conifer
- How the hygienist shortage will shape the future of dentistry
- Humana expands cardiac care partnerships for Medicare Advantage
- Virginia physician group acquired after 25+ years of independence
- Principal acquires largest dental network in Alabama
- Why private practice will survive in the DSO era
- ‘We’re running in when others are running out’: Stability drives record growth for regional Medicare Advantage plans
- California provider opens teen mental health center
- Idaho GI group cuts appointment wait times with virtual platform
- 6 Texas physicians to pay $5M to settle false claims allegations
- Inside Huntsman’s hybrid model boosting social worker capacity sixfold
- 12 dental technology updates to know
- Imagen Dental Partners adds California practice
- South Carolina’s largest independent multispecialty group acquired
- Gastroenterology and private equity in 2026: 5 notes
- WHO calls for environmentally friendly, less invasive dental care: 5 notes
- The GI physician shortage by state, by 2036
- ASC vs. HOPD costs for 5 orthopedic procedures
- Federal lawmakers introduce bill to reverse Medicaid cuts, expand Medicare dental coverage: 4 notes
- Maryland awards $1.6M for substance use disorder, peer recovery workforce expansion
- Pfizer CEO Albert Bourla on FDA official Vinay Prasad: 'We have a problem with the leadership of CBER'
- SSM Health adds gastroenterologist
- San Diego provider opens 32-bed residential mental health facility
- AI Therapist? It Falls Short, a New Study Warns
- Nevada hospital to downsize, switch to rural emergency status
- Mental health providers subject to ban on youth ‘transition’ procedures: Texas attorney general
- Moody’s downgrades Arkansas system’s credit rating
- Innovate 32 continues growth, adds 2 dental practices in Tennessee
- Grow Therapy scores $150M to build out enterprise partnerships with docs, employers
- Indiana hospital transitions revenue cycle operations to Revology
- Mayo Clinic posts 6.8% margin in 2025
- Nearly 20 States Scale Back HIV Medication Programs
- BBQ Sauce Recall Issued Nationwide Due To Incorrect Label
- FDA Recalls More Than 651,000 Jugs of Water Over Sanitation Concerns
- Listen to the Latest ‘KFF Health News Minute’
- Corewell Health posts 1.6% operating margin, grows revenue to $17.6B — 7 things to know
- Hasta los pacientes se sorprenden por los precios que sus aseguradoras están dispuestas a pagar, un costo que al final pagamos todos
- Patients with multiple chronic diseases are a looming threat to health systems' financials: Vizient
- Guardant picks Patrick Dempsey for colorectal cancer blood test awareness
- Breast Cancer Cases, Deaths Expected To Rise Worldwide
- Collagen Supplements Good For Skin, Arthritis, Evidence Review Concludes
- Illicit Adderall Use Places Stress On The Heart, Study Shows
- A-Fib Drug, Diltiazem, Could Interact With Blood Thinners, Increase Risk Of Dangerous Bleeding
- How to Get Ready For Daylight Saving Time
- Effective Sunscreen Protection Can Cost $40 A Year
- Longtime Cigna CEO David Cordani to retire, Brian Evanko tapped as successor
- Acadia, undaunted by recent EU rejection, seeks CHMP re-examination of Rett syndrome med Daybue
- FDA’s CRLs reveal critical errors in AstraZeneca’s Saphnelo data, efficacy doubts for GSK’s Exdensur
- Readers Lean On Congress To Solve Crises in Research and Rehab
- Federal Aid for Lead Cleanup Is Receding. That’s a Problem for Cash-Strapped Cities.
- Even Patients Are Shocked by the Prices Their Insurers Will Pay — And It Costs All of Us
- Disc lays off 20% of employees to steady ship after FDA rejection of rare disease drug
- Novo plugs $500M into Ireland plant to produce Wegovy pill for markets outside US
- Esperion pays $75M-plus to acquire Corstasis and newly approved Enbumyst
- Children’s Mercy raises $150M for mental healthcare
- California awards $291M to expand behavioral health housing, services
- OhioHealth builds well-being programs to reshape caregiver culture
- Lawmakers introduce bill to reverse Medicaid cuts, expand Medicare benefits
- 100+ organizations call on CMS to revise 2027 MA rates
- UNC Health Appalachian offers psychiatric physician training program
- UHS to roll out behavioral health revenue cycle AI tools in 2026
- In 1 state, large hospitals dominate 340B's net savings
- HHS bans Claude AI tool as Trump seeks full government blacklisting of Anthropic
- Report: Most states investing in value-based care with Rural Health Transformation Program
- U.S. Tops 1,100 Measles Cases This Year as Outbreaks Grow
- FDA To Offer Cash Bonuses for Faster Drug Reviews
- 'One2PrEP': Gilead's 1st Yeztugo DTC ad reimagines hit song to highlight biannual dosing
- GLP-1s support heart attack recovery in rodents by relaxing tight blood vessels
- Former Optum CEO Heather Cianfrocco to depart UnitedHealth Group
- New Drug, Acoziborole, Could Boost Efforts to Wipe Out Sleeping Sickness
- Chocolate Male Supplement Recalled Over Hidden Erectile Dysfunction Drug
- Amid unfolding Middle East war, pharma giants keep close eye on employee safety, supply chains
- CMS set to suspend enrollment in Elevance Health's Medicare Advantage plans
- Providers urge Education Department to reconsider which jobs face stiffer student loan caps
- Kennedy adds 2 new members to CDC’s vaccine panel ahead of delayed meeting
- Kennedy adds 2 new members to CDC’s vaccine panel ahead of delayed meeting
- Urban Traffic Noise Disrupts Sleep, Affects Heart Health After One Night
- Hormone Therapy Might Be Unnecessary For Some Prostate Cancer Patients
- Benzodiazepine Use Down In U.S., But OD Risk Remains, Study Says
- GLP-1 Drugs Might Ease Chronic Migraine, Study Says
- Blood Test Reveals Alcohol-Related Liver Disease
- Telemedicine Visits Cost Five Times Less Than In-Clinic Care
- Families Defend Disability Services Amid Medicaid Cuts
- Medicaid Is Paying for More Dental Care. GOP Cuts Threaten To Reverse the Trend.
- Bavarian Nordic CEO to follow board chair out the door after failed private equity takeover
- Ascendis gains more altitude with FDA approval for dwarfism drug Yuviwel
- CDMO Quotient extends Ipsen supply pact for rare disease drug Sohonos
- Quest Diagnostics launches Google-powered AI chatbot to help patients understand lab results
- Tennr takes aim at phone call bottlenecks as it builds out automation for patient referral process
- DoseSpot, Arrive Health merge to combine prescribing tools with pharmacy, medical benefit data
- Why Digital Tool are Needed to Cope with Increasing Pressures in MedTech Innovation
- Why Digital Tool are Needed to Cope with Increasing Pressures in MedTech Innovation
- Electronics Pollution Pose Added Threat to Endangered Dolphins, Porpoises
- Flea And Tick Pills May Pose Environmental Risks, Study Finds
- ICE, ALS, Addiction Medicine, and Robotic Ultrasounds: Journalists Sound Off on All That and More
- A Canadian Hospital Scoops Up Nurses Who No Longer Feel Safe in Trump’s America
- Statement on the Adoption of Final Rules Under the Holding Foreign Insiders Accountable Act
- Statement on Final Rules for the Holding Foreign Insiders Accountable Act
- State Medicaid budgets to weather $664B reduction through 2034 due to OBBBA: RAND
- Clover Health CEO said company sees opportunity in complex MA environment
- How pharma marketers are capturing the power of podcasts to connect with consumers
- Cigna's Evernorth quietly acquires hospital pharmacy CarepathRx
- Walgreens debuts virtual weight management clinic with access to GLP-1 meds
- New Obamacare Rules Could Raise Deductibles to $31K For Families
- Study Suggests One Common Amino Acid May Affect How Long Men Live
- Merck to wind down Gardasil production at N.C. plant, lay off 150-plus
- Walmart Great Value Cottage Cheese Recalled Over Pasteurization Issue
- Chris Bosh Says He’s 'Lucky To Be Alive' After Sudden Health Scare
- Patrick Kennedy: Collab with MAHA is essential to address mental health crisis
- Lilly debuts Nvidia supercomputer with fanfare and focus on escaping traditional pharma lifecycle
- Alignment CEO John Kao offers measured response to proposed 2027 MA rates
- Sanofi, Genentech, Kedrion back star-studded bleeding disorder awareness campaign
- Op-ed: Our patients deserve better safety reporting. AI could be the answer
- Blood Test Can Predict Short-Term Survival Among Seniors
- How the Brain Learns to Have Seizures During Sleep
- Why Turning 19 Spikes Medicaid Loss for Millions
- Crash Course Might Speed Brain Stimulation Treatment For Depression, Study Suggests
- Wildfire Smoke Linked To Increase In Violent Assaults
- More Parents Are Refusing A Life-Saving Shot For Their Newborns, Study Finds
- To Avoid Care Disruptions, Know When the Clock Runs Out on Your Prior Authorization
- Lake Nona Impact Forum: There can't be longevity without tech
- FDA Approval for BIOTRONIK Solia CSP S Pacing Lead For LBBAP
- FDA Approval for BIOTRONIK Solia CSP S Pacing Lead For LBBAP
- Catalyst OrthoScience gets FDA 510(k) Clearance of Archer® Patient-Specific Instrumentation for Shoulder Arthroplasty
- Catalyst OrthoScience gets FDA 510(k) Clearance of Archer® Patient-Specific Instrumentation for Shoulder Arthroplasty
- Smith+Nephew signs distribution agreement with SI-BONE
- Smith+Nephew signs distribution agreement with SI-BONE
- Quantum Surgical Acquires NeuWave Medical, Inc.
- Quantum Surgical Acquires NeuWave Medical, Inc.
- Partnering to Advance Drug Delivery Innovation
- How Pharma is Expanding its Global Footprint to Advance Clinical Research
- CFO Mark Kaye to take the helm at Carelon in leadership shake-up at Elevance Health
- Stryker launches Synchfix™ EVT, expanding options for flexible syndesmotic fixation
- Stryker launches Synchfix™ EVT, expanding options for flexible syndesmotic fixation
- Democrat-Led States Sue Trump Administration Over Cuts to Childhood Vaccine Schedule
- CDC Vaccine Advisory Panel To Revisit COVID Shot Safety Next Month
Cui bono?
(Who benefits?) is not just for crime investigation! It's the #1 question to ask when the rules change for your healthcare or your license/workplace.
The Bureau of Professional Licensing (BPL) within the Department of Licensing and Regulatory Affairs (LARA) would like to inform you that the new Pharmacy Administrative Rules were effective as of February 29, 2024. A list of the notable changes is below. This is not intended to provide a comprehensive listing of all changes or current requirements. Licensees should review the rules and statute for a complete understanding of all applicable requirements.
The summary of changes is below:
For Pharmacy Services in Medical Institutions: Updates were made indicate that the limited number of medications may be stocked in patient care areas if pharmacist review and interpretation of the order before the administration of the first dose would adversely affect the patient’s medical condition.
For Pharmacist Licenses:
An individual participating in an unconventional internship is required to annually submit an affidavit from the internship supervisor including the type of activities performed and the number of hours completed.
A graduate from a program outside the United States may petition the board for approval of a maximum of 1,400 internship hours if the hours are not obtained through an approved educational program or under the personal charge of a Michigan-licensed pharmacist.
An internship preceptor is required to submit an affidavit including the number of internship hours completed by the intern in the practice of pharmacy, unless the hours are completed in an educational program.
The Multistate Pharmacy Jurisprudence Examination requirement is eliminated and replaced with an attestation that the applicant has sufficient knowledge of the Public Health Code and the Board of Pharmacy’s rules to competently practice pharmacy in Michigan.
For Pharmacy Licenses:If a pharmacist in charge (PIC) is unable to fulfil their duties for 120 consecutive days, the pharmacy shall appoint a new PIC and notify the department.
The 2023 revisions of USP Chapters 795 and 797 are adopted, with the exception of flavoring; inspection requirements are modified, including a 2-step inspection process for an in-state pharmacy that will compound sterile products and requiring out-of-state pharmacies that will not ship compounded sterile products into Michigan to submit inspections from their resident state boards of pharmacy or the National Association of Boards of Pharmacy (NABP) Verified Pharmacy Program.
Requirements for a pharmacy’s access to pharmacy laws and rules and reference texts are clarified.
A pharmacy that dispenses drugs is required to maintain a sink with running water, a refrigerator for the exclusive use of prescription drugs, and a telephone.
For Manufacturer Licenses:If a PIC or facility manager is unable to fulfil their duties for 120 consecutive days, the pharmacy shall appoint a new PIC or facility manager and notify the department.
Inspection and accreditation requirements were modified to provide the option of submitting an inspection from the United States Food and Drug Administration, the manufacturer’s resident state board of pharmacy, or NABP drug distributor accreditation.
For Wholesale Distributor and Wholesale Distributor-Broker Licenses:If a PIC or facility manager is unable to fulfil their duties for 120 consecutive days, the pharmacy shall appoint a new PIC or facility manager and notify the department.
For the Practice of Pharmacy:If a pharmacy intern completes final product verification under the supervision of a pharmacist, initials of both the pharmacy intern and the delegating pharmacist are required; modifies the locations where a pharmacy may operate an automated device; requires pharmacist review of orders and authorization of further dispensing within 48 hours when an automatic device is used as an after-hours cabinet, emergency kit, or when the system is accessed to treat the emergent needs of a patient;
The requirements for automated devices used in non-inpatient settings and in medical institutions were clarified.
A pharmacist may remotely access a pharmacy database as well as any other necessary databases that are routinely accessed to perform their functions and requires the pharmacist to provide adequate security.
The requirements for a pharmacist to dispense an emergency supply of insulin.
Please click HERE to view the revised Pharmacy rules.Our office is diligently working on updating relative information on our website to reflect the revisions of the revised rules. For more information, please visit our website at www.michigan.gov/bpl.
Please send questions about the revised rules to BPLHELP@michigan.gov.
More on the elimination of the Multistate Pharmacy Jurisprudence Examination requirement for pharmacist licenses:
Legal exam removed from pharmacist certification in Michigan
By Dustin Walsh - March 11, 2024It’s now easier to become a licensed pharmacist in the state of Michigan.
State regulators recently eliminated a widely used certification requirement by removing the Multistate Pharmacy Jurisprudence Exam, becoming only the second state in the U.S. to do so.
The jurisprudence exam is a 2.5-hour, 120-question multiple choice examination of federal and state laws formerly required in the state to become a certified pharmacist. Pharmacists are the only discipline in health care required to pass a law exam to receive licensure.
Experts are torn on whether removing the exam will jeopardize industry safety at a time when pharmacists are seeking more autonomy in the health care industry.
Keep up with all things West Michigan business. Sign up for our free newsletters today.
The elimination of the exam was quickly pushed through the Michigan Board of Pharmacy last summer in a controversial move and the new set of regulator rules was submitted to the Joint Committee on Administrative Rules in the legislature in July.
The committee finalized axing the exam on Feb. 29 and filed the rule change with the Secretary of State, making it official.
The elimination of the exam was supported by many in the industry, including national pharmacy chains and pharmacy benefits manager organizations.
During public comment last June, several individuals spoke in favor of getting rid of the exam. While none of the commenters disclosed their affiliations, at least one appeared to be a representative of a major insurer.
Jessica Morris, who according to her LinkedIn profile is a clinical consultant of strategic partnerships for Optum Inc., the pharmacy benefits subsidiary of UnitedHealth Group — the largest health insurer in the U.S. — called the exam “pointless” due to stopgap technology that ensures pharmacists follow all laws, state and federal.
But many pharmacists in the state disagreed with its removal, including the Michigan Pharmacists Association, who submitted complaints against the removal to the Joint Committee on Administrative Rules but were ultimately unsuccessful.
Eric Roath, director of government affairs for the industry group, questioned the wholesale removal of the exam from licensure in an interview with Crain’s last year.
“Pharmacists are far more likely to be brought before the pharmacy board for potential legal violations than any other provider,” Roath said. “Physician cases are usually due to a clinical error. Pharmacy is the highest-regulated field in health care. To say there are no better solutions to ensuring practice competency than to just remove the exam is wrong. The competency assessment is actually effective in verifying.”
Detractors say it’s likely chain pharmacies and multi-state health care providers favor eliminating the jurisprudence exams across the country in a bid to control their own costs and consolidate operations. Removing the exam could make it it easier for a consolidated pharmacy center in another state to fill scripts in Michigan, a move that could save millions of dollars.
Pharmacists are also one of the more prosecuted health care professions for violating laws.
A simple Google search of health insurance fraud by pharmacists in the region reveals more than a dozen indictments in the past five years that include distributing opioids to patients without a prescription to defrauding Medicare or Medicaid for reimbursement on drugs they didn’t prescribe or sold without a prescription.
In April last year, regulators in Idaho published a white paper in the American Journal of Pharmaceutical Education that stated there has been no evidence of public safety being jeopardized by its removal of the jurisprudence exam requirement. That article was co-written by Deeb Eid, who was listed as voluntary faculty at Ferris State University’s College of Pharmacy. His full-time job, though, is as a senior advisor of regulatory affairs for CVS.
It’ll likely take years to determine whether the removal of the MJPE impacts pharmacy operations or patient safety.
Great reporting!
Quite possibly the only deregulatory measure Michigan has taken, following Idaho or not.
Sure hope it doesn't offer the "bigs" an advantage over small start-ups. Finding out should be interesting.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
















